A buyout is less likely. Any company that wanted the MNTA tech/patents to apply to FoB's would be less likely or would pay less. You don't need to see the deal terms to know that.
That makes no sense. MNTA’s patents on FoB characterization haven’t gone anywhere and are still available for development of FoB’s other than the 2-6 compounds to be commercialized by BAX.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”